UNSPSC 51262504: Betanidine sulfate

This classification denotes an antihypertensive agent and adrenergic antagonist with the molecular formula 2C10H15N3.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J4THI5N7O2, chemically known as 2-benzyl-1,3-dimethylguanidine but more generally known as betanidine sulfate, which bears US NIH Compound Identifier 2368. European Medicines Agency schedules Betanidine sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00787MIG.

Most nations, for tariff and trade purposes, schedule betanidine sulfate under HS 29252900. SMILES: CNC(=NCC1CCCCC1)NC.CNC(=NCC1CCCCC1)NC.OS(=O)(=O)O.

UNSPSC 51262504 Betanidine sulfate is a Commodity code that nominally covers a specific pharmaceutical compound, but recent state and local procurement activity under this code does not reflect purchases of betanidine sulfate itself. Instead, the single recent opportunity on record—Seminole County, Florida's IFB60459723LAS posted June 30, 2026—solicits naloxone and drug deactivation systems for community health support, a category misaligned with the code's stated pharmaceutical scope. The mismatch suggests either a data-entry error in the issuing body's UNSPSC tagging or that this code has been applied inconsistently within the jurisdiction's procurement system. The procurement itself requires quarterly deliveries of 1,900 units of naloxone and 800 safe drug deactivation systems annually to Seminole County Community Health Building in Sanford, Florida, with vendors responsible for all shipping and delivery costs and required to comply with E-Verify, drug-free workplace certification, and federal requirements including Clean Air Act and Federal Water Pollution Control Act adherence when FEMA funding is involved.

The code shows minimal recent activity suitable for vendors seeking betanidine sulfate procurement opportunities at the state and local level. Beyond the single Seminole County solicitation, no additional opportunities appear in the recent record under this code number. Interested firms should verify the actual UNSPSC coding guidance within their target jurisdictions, as the mismatch between the code's pharmaceutical definition and the naloxone-focused opportunity suggests potential system inconsistencies that may affect bid routing and vendor discovery. The Seminole County solicitation had a response deadline of July 26, 2023—a date now superseded—and included a two-year initial term with a one-year renewal option on a fixed-fee basis.